Quantcast

Latest Abbott Laboratories Stories

2014-07-28 16:24:25

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Transcriptomics Market 2014-2018 https://www.reportbuyer.com/product/2225692/Global-Transcriptomics-Market-2014-2018.html About Transcriptomics and its TypesTranscriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of organism. A transcriptome represents the set of all RNA molecules, which is a small part of the genetic...

2014-07-28 12:28:41

ABBOTT PARK, Ill., July 28, 2014 /PRNewswire/ -- Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago. "Abbott is designing the...

2014-07-25 08:25:24

- Reports Second-Quarter Adjusted EPS of $0.82, Above Previous Guidance Range of $0.75 to $0.77 (Reports GAAP EPS of $0.68) NORTH CHICAGO, Ill., July 25, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE:ABBV) today announced financial results for the second quarter ended June 30,...

2014-07-22 12:30:25

DUBLIN, July 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global IVD Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 IVDs are widely used to diagnose, monitor, and assess medical conditions, diseases, or infections usually in a controlled environment. IVD tests provide outcomes for earlier and more targeted treatment. These tests are minimally invasive, help reduce hospital stay, and provide accurate results....

2014-07-21 04:21:50

DUBLIN, July 22, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/m3xbsf/global_coronary) has announced the addition of the "Global Coronary Stents Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a tiny mesh-like tube made up of thin wires of stainless steel, cobalt-based alloy with mechanism of self-expansion. Coronary stents are used to prevent artery blockages that may occur in...

2014-07-19 23:00:39

The emerging markets including China, India, Brazil, and Mexico have became attractive for the companies engaged in the development and marketing of the hematology analyzers and reagents (http://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagents-market-153222146.html). (PRWEB) July 19, 2014 The report “Hematology Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users...

2014-07-16 20:22:18

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: In-Vitro Diagnostics Market Outlook 2018 https://www.reportbuyer.com/product/2080563/In-Vitro-Diagnostics-Market-Outlook-2018.html Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries;...

2014-07-16 08:27:34

- Second-Quarter Ongoing EPS of $0.54, Above Previous Guidance Range and Representing Double-Digit Earnings-Per-Share Growth - ABBOTT PARK, Ill., July 16, 2014 /PRNewswire/ -- Abbott today announced financial results for the second quarter ended June 30, 2014. -- Ongoing diluted EPS was $0.54 in the second quarter, representing growth of 17.4 percent, and above the previous guidance range of $0.50 to $0.52; reported diluted EPS from continuing operations under GAAP...

2014-07-14 08:25:52

Abbott will retain its branded generics pharmaceuticals business in emerging markets ABBOTT PARK, Ill., July 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business, and will be a publicly traded company. This represents a value of approximately...

2014-07-08 23:02:49

RnRMarketResearch.com adds “World Glucose Self-Testing Markets” and “U.S. Glucose Testing Markets” to its store. The report describes the specific market segments for blood glucose testing and diabetes management in the U.S. and the world market. Dallas, Texas (PRWEB) July 08, 2014 World Glucose Self-Testing Markets The purpose of this World Glucose Self-Testing Markets (http://www.rnrmarketresearch.com/world-glucose-self-testing-markets-market-report.html) report is to provide a...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related